Be part of the knowledge.™

Innovations in Oncology: Gynecologic Cancers

Are you up to date on the key clinical data for available immuno-oncologic agents in advanced endometrial and cervical cancers?

This educational series examines the significance and potential impact of immunotherapy and antibody-drug conjugates in patients with advanced endometrial and cervical cancers. Our global experts discuss key clinical data from first- and second-line treatment, management considerations during immuno-oncologic therapy, and more!

Provided by:

In Partnership with:

2

LikeLikedUnlike

Episodes 1-12 of 12

First-Line Maintenance Therapy Using PARP Inhibitors for Ovarian Cancer
MinuteCE®
First-Line Maintenance Therapy Using PARP Inhibitors for Ovarian Cancer
- Nicoletta Colombo, MD
  Peer
- Ritu Salani, MD, MBA
  Peer
1.00 program credits
Clinical Evidence Behind Emerging Targeted Therapy Strategies Across Gynecologic Malignances
MinuteCE®
Clinical Evidence Behind Emerging Targeted Therapy Strategies Across Gynecologic Malignances
- Nicoletta Colombo, MD
  Peer
1.00 program credits
Guideline Recommendations for Biomarker-Directed Therapies in Cervical Cancer
MinuteCE®
Guideline Recommendations for Biomarker-Directed Therapies in Cervical Cancer
- Ritu Salani, MD, MBA
  Peer
- Nicoletta Colombo, MD
  Peer
1.00 program credits
Implementing Guideline-Concordant Care Into the Management of Frontline Patients With Recurrent Endometrial Cancer
MinuteCE®
Implementing Guideline-Concordant Care Into the Management of Frontline Patients With Recurrent Endometrial Cancer
- Ritu Salani, MD, MBA
  Peer
- Susana Campos, MD, MPH
  Peer
1.00 program credits
Targeted Therapy in the Treatment of Recurrent Platinum-Resistant Ovarian Cancer
MinuteCE®
Targeted Therapy in the Treatment of Recurrent Platinum-Resistant Ovarian Cancer
- Ritu Salani, MD, MBA
  Peer
- Nicoletta Colombo, MD
  Peer
1.00 program credits
Insights From Global Key Opinion Leaders on Optimizing Patient Care in Gynecologic Malignances
MinuteCE®
Insights From Global Key Opinion Leaders on Optimizing Patient Care in Gynecologic Malignances
- Susana Campos, MD, MPH
  Peer
- Nicoletta Colombo, MD
  Peer
1.00 program credits
advertisement
Guideline Considerations for Immunotherapy in Primary Advanced or Recurrent Endometrial Cancer
MinuteCE®
Guideline Considerations for Immunotherapy in Primary Advanced or Recurrent Endometrial Cancer
- Susana Campos, MD, MPH
  Peer
- Ritu Salani, MD, MBA
  Peer
1.00 program credits
Emerging and Practice-Changing Directions in Gynecologic Malignances Involving Combination Therapies With Immune Checkpoint Inhibitors
MinuteCE®
Emerging and Practice-Changing Directions in Gynecologic Malignances Involving Combination Therapies With Immune Checkpoint Inhibitors
- Susana Campos, MD, MPH
  Peer
1.00 program credits
Implementing Guideline-Concordant Care Into a Targeted Therapy Approach for Patients With Platinum-Resistant Ovarian Cancer
MinuteCE®
Implementing Guideline-Concordant Care Into a Targeted Therapy Approach for Patients With Platinum-Resistant Ovarian Cancer
- Susana Campos, MD, MPH
  Peer
- Ritu Salani, MD, MBA
  Peer
1.00 program credits
Guideline-Based, Biomarker-Directed Treatment Options in Second-Line Recurrent Endometrial Cancer
MinuteCE®
Guideline-Based, Biomarker-Directed Treatment Options in Second-Line Recurrent Endometrial Cancer
- Nicoletta Colombo, MD
  Peer
- Susana Campos, MD, MPH
  Peer
1.00 program credits
MinuteCE®
Innovations in Oncology Learning Center From Guidelines to Practice: Gynecologic Cancer
- Susana Campos, MD, MPH
  Peer
- Nicoletta Colombo, MD
  Peer
- Ritu Salani, MD, MBA
  Peer
1.00 credits 10 episodes
Employing Immunotherapy and ADCs in Advanced Endometrial and Cervical Cancers: Current and Emerging Therapies
CME/CE
Employing Immunotherapy and ADCs in Advanced Endometrial and Cervical Cancers: Current and Emerging Therapies
- Robert L. Coleman, MD, FACOG, FACS
  Peer
- Susana Campos, MD, MPH
  Peer
- Domenica Lorusso, MD, PhD
  Peer
advertisement

Program Chapters

Segment Chapters

Playlist:

Recommended